AAPL 10-Q: Smart Summary
Consolidated Statements of Operations
| Three Months Ended | |||||||||||||||||||||||
| December 27, 2025 | December 28, 2024 | ||||||||||||||||||||||
| Net sales: | |||||||||||||||||||||||
| Products | $ | 113,743 | $ | 97,960 | |||||||||||||||||||
| Services | 30,013 | 26,340 | |||||||||||||||||||||
| Total net sales | 143,756 | 124,300 | |||||||||||||||||||||
| Cost of sales: | |||||||||||||||||||||||
| Products | 67,478 | 59,447 | |||||||||||||||||||||
| Services | 7,047 | 6,578 | |||||||||||||||||||||
| Total cost of sales | 74,525 | 66,025 | |||||||||||||||||||||
| Gross margin | 69,231 | 58,275 | |||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 10,887 | 8,268 | |||||||||||||||||||||
| Selling, general and administrative | 7,492 | 7,175 | |||||||||||||||||||||
| Total operating expenses | 18,379 | 15,443 | |||||||||||||||||||||
| Operating income | 50,852 | 42,832 | |||||||||||||||||||||
| Other income/(expense), net | 150 | (248) | |||||||||||||||||||||
| Income before provision for income taxes | 51,002 | 42,584 | |||||||||||||||||||||
| Provision for income taxes | 8,905 | 6,254 | |||||||||||||||||||||
| Net income | $ | 42,097 | $ | 36,330 | |||||||||||||||||||
| Earnings per share: | |||||||||||||||||||||||
| Basic | $ | 2.85 | $ | 2.41 | |||||||||||||||||||
| Diluted | $ | 2.84 | $ | 2.40 | |||||||||||||||||||
| Shares used in computing earnings per share: | |||||||||||||||||||||||
| Basic | 14,748,158 | 15,081,724 | |||||||||||||||||||||
| Diluted | 14,810,356 | 15,150,865 | |||||||||||||||||||||
Consolidated Balance Sheets
| December 27, 2025 | September 27, 2025 | ||||||||||
| ASSETS: | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 45,317 | $ | 35,934 | |||||||
| Marketable securities | 21,590 | 18,763 | |||||||||
| Accounts receivable, net | 39,921 | 39,777 | |||||||||
| Vendor non-trade receivables | 30,399 | 33,180 | |||||||||
| Inventories | 5,875 | 5,718 | |||||||||
| Other current assets | 15,002 | 14,585 | |||||||||
| Total current assets | 158,104 | 147,957 | |||||||||
| Non-current assets: | |||||||||||
| Marketable securities | 77,888 | 77,723 | |||||||||
| Property, plant and equipment, net | 50,159 | 49,834 | |||||||||
| Other non-current assets | 93,146 | 83,727 | |||||||||
| Total non-current assets | 221,193 | 211,284 | |||||||||
| Total assets | $ | 379,297 | $ | 359,241 | |||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY: | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 70,587 | $ | 69,860 | |||||||
| Other current liabilities | 68,543 | 66,387 | |||||||||
| Deferred revenue | 9,413 | 9,055 | |||||||||
| Commercial paper | 1,997 | 7,979 | |||||||||
| Term debt | 11,827 | 12,350 | |||||||||
| Total current liabilities | 162,367 | 165,631 | |||||||||
| Non-current liabilities: | |||||||||||
| Term debt | 76,685 | 78,328 | |||||||||
| Other non-current liabilities | 52,055 | 41,549 | |||||||||
| Total non-current liabilities | 128,740 | 119,877 | |||||||||
| Total liabilities | 291,107 | 285,508 | |||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity: | |||||||||||
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,702,703 and 14,773,260 shares issued and outstanding, respectively | 95,221 | 93,568 | |||||||||
| Accumulated deficit | (2,177) | (14,264) | |||||||||
| Accumulated other comprehensive loss | (4,854) | (5,571) | |||||||||
| Total shareholders’ equity | 88,190 | 73,733 | |||||||||
| Total liabilities and shareholders’ equity | $ | 379,297 | $ | 359,241 | |||||||
Consolidated Statements of Cash Flows
| Three Months Ended | |||||||||||
| December 27, 2025 | December 28, 2024 | ||||||||||
Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances | $ | 35,934 | $ | 29,943 | |||||||
| Operating activities: | |||||||||||
| Net income | 42,097 | 36,330 | |||||||||
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||||
| Depreciation and amortization | 3,214 | 3,080 | |||||||||
| Share-based compensation expense | 3,594 | 3,286 | |||||||||
| Other | (528) | (2,009) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable, net | (153) | 3,597 | |||||||||
| Vendor non-trade receivables | 2,781 | 3,166 | |||||||||
| Inventories | (211) | 215 | |||||||||
| Other current and non-current assets | (10,250) | 939 | |||||||||
| Accounts payable | 848 | (6,671) | |||||||||
| Other current and non-current liabilities | 12,533 | (11,998) | |||||||||
| Cash generated by operating activities | 53,925 | 29,935 | |||||||||
| Investing activities: | |||||||||||
| Purchases of marketable securities | (12,693) | (6,124) | |||||||||
| Proceeds from maturities of marketable securities | 7,510 | 15,967 | |||||||||
| Proceeds from sales of marketable securities | 2,824 | 3,492 | |||||||||
| Payments for acquisition of property, plant and equipment | (2,373) | (2,940) | |||||||||
| Other | (154) | (603) | |||||||||
| Cash generated by/(used in) investing activities | (4,886) | 9,792 | |||||||||
| Financing activities: | |||||||||||
| Payments for taxes related to net share settlement of equity awards | (2,922) | (2,921) | |||||||||
| Payments for dividends and dividend equivalents | (3,921) | (3,856) | |||||||||
| Repurchases of common stock | (24,701) | (23,606) | |||||||||
| Repayments of term debt | (2,164) | (1,009) | |||||||||
| Repayments of commercial paper, net | (5,910) | (7,944) | |||||||||
| Other | (38) | (35) | |||||||||
| Cash used in financing activities | (39,656) | (39,371) | |||||||||
| Increase in cash, cash equivalents, and restricted cash and cash equivalents | 9,383 | 356 | |||||||||
Cash, cash equivalents, and restricted cash and cash equivalents, ending balances | $ | 45,317 | $ | 30,299 | |||||||
| Supplemental cash flow disclosure: | |||||||||||
| Cash paid for income taxes, net | $ | 3,434 | $ | 18,651 | |||||||
Consolidated Statements of Comprehensive Income
| Three Months Ended | |||||||||||||||||||||||
| December 27, 2025 | December 28, 2024 | ||||||||||||||||||||||
| Net income | $ | 42,097 | $ | 36,330 | |||||||||||||||||||
| Other comprehensive income/(loss): | |||||||||||||||||||||||
| Change in foreign currency translation, net of tax | (159) | (625) | |||||||||||||||||||||
| Change in unrealized gains/losses on derivative instruments, net of tax: | |||||||||||||||||||||||
| Change in fair value of derivative instruments | 211 | 1,651 | |||||||||||||||||||||
| Adjustment for net (gains)/losses realized and included in net income | 237 | 784 | |||||||||||||||||||||
| Total change in unrealized gains/losses on derivative instruments | 448 | 2,435 | |||||||||||||||||||||
| Change in unrealized gains/losses on marketable debt securities, net of tax: | |||||||||||||||||||||||
| Change in fair value of marketable debt securities | 424 | (1,647) | |||||||||||||||||||||
| Adjustment for net (gains)/losses realized and included in net income | 4 | 220 | |||||||||||||||||||||
| Total change in unrealized gains/losses on marketable debt securities | 428 | (1,427) | |||||||||||||||||||||
| Total other comprehensive income | 717 | 383 | |||||||||||||||||||||
| Total comprehensive income | $ | 42,814 | $ | 36,713 | |||||||||||||||||||
Notes to Financials
Note 1: Summary of Significant Accounting Policies
Boilerplate only. Nothing of substance to surface.
Note 2: Revenue
- Deferred revenue recognized: $4B of the three months ended December 27, 2025 net sales was previously deferred as of the beginning of the period, compared to $3.7B in the prior-year period.
- Deferred revenue balance: Total deferred revenue was $14.3B as of December 27, 2025 and $13.7B as of September 27, 2025; 66% is expected to be realized in less than a year, 23% within one-to-two years, 9% within two-to-three years, and 2% in greater than three years.
- Geographic mix note: The proportion of net sales by revenue source was generally consistent across reportable segments, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.
in millions
Three Months Ended December 27, 2025
Three Months Ended December 28, 2024
| Segment | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| iPhone | $85,269 | $69,138 | +23.3% |
| Mac | $8,386 | $8,987 | -6.7% |
| iPad | $8,595 | $8,088 | +6.3% |
| Wearables, Home and Accessories | $11,493 | $11,747 | -2.2% |
| Services | $30,013 | $26,340 | +13.9% |
| Total | $143,756 | $124,300 | +15.7% |
Note 3: Earnings Per Share
in —
| Line item | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| Net income (millions) | 42,097 | 36,330 | +15.9% |
| Weighted-average basic shares outstanding (thousands) | 14,748,158 | 15,081,724 | -2.2% |
| Effect of dilutive share-based awards (thousands) | 62,198 | 69,141 | -10.0% |
| Weighted-average diluted shares (thousands) | 14,810,356 | 15,150,865 | -2.2% |
| Basic earnings per share | 2.85 | 2.41 | +18.3% |
| Diluted earnings per share | 2.84 | 2.40 | +18.3% |
Note 4: Financial Instruments
- Portfolio size and composition: Total cash, cash equivalents, and marketable securities had a fair value of $144.8B as of December 27, 2025 (adjusted cost $146.5B), up from $132.4B (adjusted cost $134.7B) as of September 27, 2025; the portfolio carried net unrealized losses of ($2.5B) and ($3B) at the respective dates, with Level 2 instruments (primarily corporate debt, mortgage- and asset-backed, and U.S. Treasury securities) comprising the vast majority of holdings.
- Maturity profile: As of December 27, 2025, 78% of non-current marketable debt securities (excluding mortgage- and asset-backed) had maturities between 1 and 5 years, 17% between 5 and 10 years, and 5% greater than 10 years; for non-current mortgage- and asset-backed securities, 12% mature between 1 and 5 years, 18% between 5 and 10 years, and 70% greater than 10 years.
- Derivative instruments: Notional value of foreign exchange contracts designated as accounting hedges declined to $46.6B from $62.6B quarter-over-quarter, while non-designated foreign exchange contracts increased to $121B from $109.1B; interest rate contracts held steady at $12.9B; the carrying amount of term debt subject to fair value hedges was $12.6B at both dates; maximum hedging length for term debt-related foreign currency exposure is 17 years.
- Receivables concentration: As of December 27, 2025, 2 trade receivable customers individually represented 15% and 10% of total trade receivables, and third-party cellular network carriers accounted for 35%; 2 manufacturing vendors accounted for 47% and 26% of total vendor non-trade receivables.
in millions
| Line item | December 27, 2025 | September 27, 2025 | YoY |
|---|---|---|---|
| Cash | 30,826 | 28,267 | +9.1% |
| Money market funds (Level 1) | 5,959 | 5,272 | +13.0% |
| Mutual funds (Level 1) | 985 | 854 | +15.3% |
| U.S. Treasury securities (Level 2) | 18,568 | 15,848 | +17.2% |
| U.S. agency securities (Level 2) | 8,579 | 5,120 | +67.6% |
| Non-U.S. government securities (Level 2) | 6,393 | 6,273 | +1.9% |
| Certificates of deposit and time deposits (Level 2) | 1,737 | 917 | +89.4% |
| Commercial paper (Level 2) | 991 | 100 | +891.0% |
| Corporate debt securities (Level 2) | 46,267 | 46,560 | -0.6% |
| Municipal securities (Level 2) | 153 | 205 | -25.4% |
| Mortgage- and asset-backed securities (Level 2) | 24,337 | 23,004 | +5.8% |
Note 5: Condensed Consolidated Financial Statement Details
Property, plant and equipment: Gross PP&E was $127.3B as of December 27, 2025 (vs. $125.8B as of September 27, 2025), with accumulated depreciation of ($77.2B) (vs. ($76B)), yielding net PP&E of $50.2B (vs. $49.8B).
in millions
| Line item | December 27, 2025 | September 27, 2025 | YoY |
|---|---|---|---|
| Gross property, plant and equipment | 127,320 | 125,848 | +1.2% |
| Accumulated depreciation | (77,161) | (76,014) | +1.5% |
Note 6: Debt
- Commercial paper outstanding: As of December 27, 2025 and September 27, 2025, the Company had $2B and $8B of commercial paper outstanding, respectively; net proceeds are used for general corporate purposes, including dividends and share repurchases.
- Commercial paper repayments: For the three months ended December 27, 2025, total repayments of commercial paper, net were ($5.9B), composed of ($2.1B) for maturities 90 days or less and ($3.8B) for maturities greater than 90 days; comparable repayments for the three months ended December 28, 2024 were ($7.9B) (all maturities 90 days or less).
- Term debt carrying amount: As of December 27, 2025 and September 27, 2025, the aggregate carrying amount of outstanding fixed-rate notes was $88.5B and $90.7B, respectively.
- Term debt fair value: Based on Level 2 inputs, the fair value of the Notes was $78.1B as of December 27, 2025 and $80.4B as of September 27, 2025.
in millions
| Line item | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| Repayments of commercial paper, net (maturities 90 days or less) | (2,122) | (7,944) | -73.3% |
| Repayments of commercial paper (maturities greater than 90 days) | (3,788) | 0 | — |
Note 7: Shareholders’ Equity
- Share repurchases: During the three months ended December 27, 2025, the Company repurchased 93 million shares of its common stock for $25B under its share repurchase program, which does not obligate the Company to acquire a minimum amount of shares; repurchases may occur in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.
Note 8: Share-Based Compensation
- RSU activity: The RSU balance grew from 151,574 thousand as of September 27, 2025 to 176,096 thousand as of December 27, 2025, with 61,897 thousand RSUs granted at a weighted-average grant-date fair value of $256.22 per RSU, 33,905 thousand vested at $173.00, and 3,470 thousand forfeited at $208.14; the weighted-average grant-date fair value of the ending balance was $215.98 per RSU.
- Vesting-date fair value: Total vesting-date fair value of RSUs was $8.6B for the three months ended December 27, 2025, compared to $8.4B for the three months ended December 28, 2024.
- Unrecognized compensation cost: As of December 27, 2025, total unrecognized compensation cost related to outstanding RSUs was $31.5B, expected to be recognized over a weighted-average period of 2.9 years.
in millions
| Line item | December 27, 2025 | December 28, 2024 | YoY |
|---|---|---|---|
| Share-based compensation expense | 3,594 | 3,286 | +9.4% |
| Income tax benefit related to share-based compensation expense | (1,293) | (1,332) | -2.9% |
Note 9: Commitments and Contingencies
Commitments
- Unconditional purchase obligations ($33.2B total as of December 27, 2025): Supplier arrangements, licensed intellectual property and content, and distribution rights; payments of $4,754M (remaining 2026), $8,066M (2027), $7,005M (2028), $6,538M (2029), $5,992M (2030), and $827M thereafter.
Legal Proceedings
- Various legal proceedings (ordinary course): Management opined there was not at least a reasonable possibility the Company incurred a material loss, or a material loss greater than a recorded accrual, for asserted legal and other claims.
Note 10: Segment Information
- Segment structure: The company reports 5 geographic reportable segments — Americas, Europe, Greater China, Japan, and Rest of Asia Pacific — plus a Corporate category that captures Research and development and General and administrative expenses not allocated to geographic segments.
- Corporate allocation: Selling and marketing costs are allocated to geographic segments, while Research and development and General and administrative are reported entirely within Corporate; Net sales in the Corporate segment are zero in both periods.
in millions
| Line item | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| Americas — Net sales | 58,529 | 52,648 | +11.2% |
| Americas — Cost of sales | (31,849) | (28,495) | +11.8% |
| Americas — Selling and marketing | (2,727) | (2,644) | +3.1% |
| Americas — Operating income/(loss) | 23,953 | 21,509 | +11.4% |
| Europe — Net sales | 38,146 | 33,861 | +12.7% |
| Europe — Cost of sales | (19,061) | (18,043) | +5.6% |
| Europe — Selling and marketing | (1,295) | (1,211) | +6.9% |
| Europe — Operating income/(loss) | 17,790 | 14,607 | +21.8% |
| Greater China — Net sales | 25,526 | 18,513 | +37.9% |
| Greater China — Cost of sales | (13,030) | (9,759) | +33.5% |
| Greater China — Selling and marketing | (704) | (594) | +18.5% |
| Greater China — Operating income/(loss) | 11,792 | 8,160 | +44.5% |
| Japan — Net sales | 9,413 | 8,987 | +4.7% |
| Japan — Cost of sales | (4,511) | (4,393) | +2.7% |
| Japan — Selling and marketing | (289) | (280) | +3.2% |
| Japan — Operating income/(loss) | 4,613 | 4,314 | +6.9% |
| Rest of Asia Pacific — Net sales | 12,142 | 10,291 | +18.0% |
| Rest of Asia Pacific — Cost of sales | (6,074) | (5,335) | +13.9% |
| Rest of Asia Pacific — Selling and marketing | (382) | (372) | +2.7% |
| Rest of Asia Pacific — Operating income/(loss) | 5,686 | 4,584 | +24.0% |
| Corporate — Research and development | (10,887) | (8,268) | +31.7% |
| Corporate — General and administrative | (2,095) | (2,074) | +1.0% |
| Corporate — Operating income/(loss) | (12,982) | (10,342) | +25.5% |
Management Discussion & Analysis
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Boilerplate only. Nothing of substance to surface.
Available Information
Boilerplate only. Nothing of substance to surface.
Business Seasonality and Product Introductions
- Seasonal pattern: The Company historically experiences higher net sales in its first quarter compared to other quarters, driven in part by seasonal holiday demand.
- Product introduction effects: New product and service introductions can significantly impact net sales, cost of sales, and operating expenses; indirect distribution channel inventory fills following a launch while older product inventory declines as a newer launch approaches, and consumer/distributor anticipation of a launch can also affect net sales.
- Q1 2026 product announcements: During the first quarter of 2026, the Company announced updated versions of the 14-inch MacBook Pro®, iPad Pro®, and Apple Vision Pro®.
Macroeconomic Conditions
Boilerplate only. Nothing of substance to surface.
Tariffs and Other Measures
- Tariff landscape: Beginning in the second quarter of 2025, new tariffs were announced on imports to the U.S., including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam, and the EU, among others, with several countries having imposed or threatened reciprocal tariffs and other retaliatory measures on U.S. imports.
- Section 232 semiconductor investigation: On January 14, 2026, initial results were published of the U.S. Department of Commerce investigation under Section 232 of the Trade Expansion Act of 1962 into imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors; the announcement did not impose any additional tariffs affecting the Company's products at this time.
- Potential adverse impacts: Tariffs and other measures applied to the Company's products or their components can have a material adverse impact on the Company's business, results of operations, and financial condition, including the Company's supply chain, the availability of rare earths and other raw materials and components, pricing, and gross margin.
- Residual uncertainty: The ultimate impact remains uncertain and depends on whether additional U.S. tariffs or other measures are announced, the extent of other countries' retaliatory measures, and the overall magnitude and duration of these measures, with broader trade disputes potentially causing shifts and reductions in consumer spending and negative consumer sentiment for the Company's products and services.
Segment Operating Performance
in millions
By Region
Three Months Ended December 27, 2025
Three Months Ended December 28, 2024
| Segment | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| Americas | $58,529 | $52,648 | +11.2% |
| Europe | $38,146 | $33,861 | +12.7% |
| Greater China | $25,526 | $18,513 | +37.9% |
| Japan | $9,413 | $8,987 | +4.7% |
| Total | $131,614 | $114,009 | +15.4% |
By Business Segment
Three Months Ended December 27, 2025
Three Months Ended December 28, 2024
| Segment | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| Rest of Asia Pacific | $12,142 | $10,291 | +18.0% |
| Total | $12,142 | $10,291 | +18.0% |
Americas
Americas net sales: Increased during the first quarter of 2026 compared to the same quarter in 2025, primarily due to higher net sales of iPhone and Services.
Europe
- Revenue drivers: Europe net sales increased in the first quarter of 2026 compared to the same quarter in 2025, primarily due to higher net sales of iPhone and Services.
- FX impact: The strength in foreign currencies relative to the U.S. dollar had a net favorable year-over-year impact on Europe net sales during the first quarter of 2026.
Greater China
Greater China revenue: Net sales increased during the first quarter of 2026 compared to the same quarter in 2025, driven by higher net sales of iPhone.
Japan
- Revenue drivers: Japan net sales increased during the first quarter of 2026 compared to the same quarter in 2025 primarily due to higher net sales of iPhone and iPad.
- Currency headwind: The weakness in the yen relative to the U.S. dollar had an unfavorable year-over-year impact on Japan net sales during the first quarter of 2026.
Rest of Asia Pacific
- Revenue drivers: Rest of Asia Pacific net sales increased during the first quarter of 2026 compared to the same quarter in 2025 primarily due to higher net sales of iPhone and Services.
Products and Services Performance
- iPhone growth: iPhone net sales rose 23% year-over-year to $85.3B, the largest absolute contributor to total net sales of $143.8B (up 16%).
- Services expansion: Services net sales grew 14% to $30B, while Mac declined 7% to $8.4B and Wearables, Home and Accessories fell 2% to $11.5B.
- iPad: iPad net sales increased 6% to $8.6B.
in millions
Three Months Ended December 27, 2025
Three Months Ended December 28, 2024
| Segment | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| iPhone | $85,269 | $69,138 | +23.3% |
| Mac | $8,386 | $8,987 | -6.7% |
| iPad | $8,595 | $8,088 | +6.3% |
| Wearables, Home and Accessories | $11,493 | $11,747 | -2.2% |
| Services | $30,013 | $26,340 | +13.9% |
| Total | $143,756 | $124,300 | +15.7% |
iPhone
- Revenue driver: iPhone net sales increased during the first quarter of 2026 compared to the same quarter in 2025 due to higher net sales of Pro models.
Mac
Revenue drivers: Mac net sales decreased during the first quarter of 2026 compared to the same quarter in 2025, primarily due to lower net sales of laptops and desktops.
iPad
iPad net sales: Increased in Q1 2026 versus Q1 2025, driven primarily by higher net sales of iPad and iPad Pro, partially offset by lower net sales of iPad mini®.
Wearables, Home and Accessories
Revenue trend: Wearables, Home and Accessories net sales decreased during the first quarter of 2026 compared to the same quarter in 2025, primarily due to lower net sales of Wearables.
Services
Revenue drivers: Services net sales increased during the first quarter of 2026 compared to the same quarter in 2025 primarily due to higher net sales from advertising, the App Store®, and cloud services.
Gross Margin
- Products gross margin %: Expanded 140 basis points year over year to 40.7% for the three months ended December 27, 2025, from 39.3% for the three months ended December 28, 2024.
- Services gross margin %: Expanded 150 basis points year over year to 76.5% from 75.0% over the same periods.
- Total gross margin %: Expanded 130 basis points to 48.2% from 46.9%.
in millions
December 27, 2025
December 28, 2024
| Segment | December 27, 2025 | December 28, 2024 | YoY |
|---|---|---|---|
| Products | $46,265 | $38,513 | +20.1% |
| Services | $22,966 | $19,762 | +16.2% |
| Total | $69,231 | $58,275 | +18.8% |
Products Gross Margin
- Gross margin drivers: Products gross margin and gross margin percentage increased in the first quarter of 2026 compared to the same quarter in 2025, primarily due to a different mix of products, partially offset by tariff costs.
Services Gross Margin
- Services gross margin: Increased in Q1 2026 versus Q1 2025, primarily due to higher Services net sales and a different mix of services.
- Services gross margin %: Also increased year-over-year, driven by a different mix of services, partially offset by higher costs.
- Forward-looking caution: The Company believes gross margins will generally be subject to volatility and downward pressure, citing risk factors discussed in the 2025 Form 10-K and this Form 10-Q.
Operating Expenses
- R&D growth: Research and development expenses rose 32% to $10.9B for the three months ended December 27, 2025, from $8.3B in the prior-year period, representing 8% of total net sales versus 7% a year ago.
- SG&A: Selling, general and administrative expenses increased 4% to $7.5B from $7.2B, declining as a share of total net sales to 5% from 6%.
- Total operating expenses: Combined operating expenses grew 19% to $18.4B from $15.4B, representing 13% of total net sales versus 12% in the prior-year period.
in millions
| Line item | December 27, 2025 | December 28, 2024 | YoY |
|---|---|---|---|
| Research and development | 10,887 | 8,268 | +31.7% |
| Selling, general and administrative | 7,492 | 7,175 | +4.4% |
Research and Development
- R&D expense drivers: Growth in R&D expense during the first quarter of 2026 compared to the same quarter in 2025 was primarily driven by increases in infrastructure-related costs, headcount-related expenses, and engineering program costs.
Selling, General and Administrative
- Primary drivers: Growth in selling, general and administrative expense during the first quarter of 2026 compared to the same quarter in 2025 was primarily driven by increases in headcount-related expenses and variable selling expenses.
Provision for Income Taxes
- Provision and effective rate: Provision for income taxes rose to $8.9B in the three months ended December 27, 2025 from $6.3B in the three months ended December 28, 2024, with the effective tax rate increasing to 17.5% from 14.7%, both below the 21% statutory federal rate.
- Rate below statutory: The effective rate was lower than the 21% statutory rate primarily due to a lower effective tax rate on foreign earnings, the U.S. federal R&D credit, and tax benefits from share-based compensation, partially offset by state income taxes.
- Year-over-year rate increase: The higher effective rate versus the first quarter of 2025 was primarily due to the impact of foreign currency loss regulations issued by the U.S. Department of the Treasury in December 2024 and the tax impact from foreign currency revaluations in the first quarter of 2025 related to the State Aid Decision.
in millions
| Line item | Three Months Ended December 27, 2025 | Three Months Ended December 28, 2024 | YoY |
|---|---|---|---|
| Provision for income taxes | 8,905 | 6,254 | +42.4% |
| Effective tax rate (%) | 17.50 | 14.70 | +19.0% |
| Statutory federal income tax rate (%) | 21 | 21 | +0.0% |
Liquidity and Capital Resources
- Liquidity adequacy: The Company believes its balances of cash, cash equivalents and marketable securities, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.
- Contractual obligations: The Company's contractual cash requirements have not changed materially since the 2025 Form 10-K, except for manufacturing purchase obligations and other purchase obligations.
Manufacturing Purchase Obligations
- Manufacturing purchase obligations: As of December 27, 2025, the Company had manufacturing purchase obligations of $44.4B, with $43.7B payable within 12 months, reflecting commitments to outsourcing partners that manufacture subassemblies, perform final assembly and testing, and a wide variety of individual component suppliers.
Other Purchase Obligations
- Composition: Other purchase obligations primarily consist of noncancelable obligations related to supplier arrangements, licensed intellectual property and content, distribution rights, and the acquisition of capital assets related to product manufacturing.
- Outstanding balance: As of December 27, 2025, total other purchase obligations were $35.1B, with $9.3B payable within 12 months.
Capital Return Program
- Share repurchase program: The program does not obligate the Company to acquire a minimum amount of shares; during Q1 2026, the Company repurchased $25B of its common stock.
- Dividends: The quarterly cash dividend was $0.26 per share as of December 27, 2025, with the Company intending to increase its dividend on an annual basis subject to Board declaration; dividends and dividend equivalents paid in Q1 2026 totaled $3.9B.
Recent Accounting Pronouncements
Internal-Use Software
Boilerplate only. Nothing of substance to surface.
Disaggregation of Income Statement Expenses
Boilerplate only. Nothing of substance to surface.
Income Taxes
Boilerplate only. Nothing of substance to surface.
Critical Accounting Estimates
Boilerplate only. Nothing of substance to surface.
More AAPL Smart Summaries
Other filings for Apple Inc. with a Smart Summary.
Never miss a AAPL filing
Get real-time email alerts when AAPL files with the SEC.